Non Hodgkin Lymphoma Clinical Trial
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study
Summary
The goal of this infrastructure grant is to establish and maintain a cohort of over 12,000 non-Hodgkin lymphoma (NHL) patients to support broad and cutting-edge research that identifies clinical (including co-morbid diseases), epidemiologic (including lifestyle and other exposures), host genetic, tumor, and treatment factors, as well as the interaction among these factors, on short and long-term outcomes. These efforts will identify new approaches to improve the survival and well-being of NHL patients.
Full Description
Newly diagnosed non-Hodgkin lymphoma (NHL) patients will be recruited from each center participating in the LEO cohort. At time of consent, participants will be asked to completed several questionnaires collecting health history, current medical and quality of life questions. Patients will also provide a baseline blood sample that will processed locally and stored centrally for future research use. Additionally, consent is given for use of excess clinical tumor tissue for research use.
Eligibility Criteria
Inclusion Criteria:
Newly diagnosed non-Hodgkin Lymphoma (NHL), within 183 days of enrollment
Patients may have been treated as long as initial NHL diagnosis is within 6 months of enrollment
18 years of age or older
Exclusion Criteria:
Lymphoma diagnosis greater than 184 days from date of consent
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 8 Locations for this study
Miami Florida, 33136, United States
Atlanta Georgia, 30322, United States
Iowa City Iowa, 52242, United States
Rochester Minnesota, 55902, United States
Saint Louis Missouri, 63130, United States
New York New York, 10021, United States
Rochester New York, 14642, United States
Houston Texas, 77030, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.